Evogene (EVGN) Tops Q1 EPS by 2c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August